|
|||||
|
|
Icotinib,an effective treatment option for patients with lung adenocarcinoma harboring compound EGFR L858R and A871G mutation |
|
| Authors: | Jin Lin-ling Wu Zhen-zhen Wang Yan-li Chen Dong-sheng Li Si Xiao Mingzhe Zhao Xin |
| Institution: | 1.Department of Respiratory and Critical Care Medicine, Jiangsu Province Hospital and The First Affiliated Hospital with Nanjing Medical University , Nanjing, 210002, China ;2.The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, 210002, China ; |
| Abstract: | Investigational New Drugs - Compound epidermal growth factor receptor (EGFR) mutations are defined as double or multiple independent mutations of the EGFR tyrosine kinase domain (TKD), in which an... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |